Related Experiment Videos
Beta-thalassemia in the Korean population
1Department of Clinical Pathology, Seoul National University College of Medicine, Korea.
International Journal of Hematology
|November 15, 2002
Summary
Beta-thalassemia, though rare in Koreans, requires molecular study for diagnosis and epidemiology. This study identified 14 beta-thalassemia mutations in 47 Korean families, revealing unique genetic origins and regional differences.
Area of Science:
- Genetics
- Hematology
- Molecular Biology
Background:
- Beta-thalassemia is uncommon in Korea but relevant for hypochromic anemia diagnosis.
- Molecular characterization is crucial for diagnosis and genetic epidemiology in the region.
Purpose of the Study:
- To analyze the molecular basis of beta-thalassemia in Korean families.
- To identify specific mutations and their origins in the Korean population.
Main Methods:
- Direct sequencing of PCR-amplified genomic DNA.
- Haplotype analysis of beta-thalassemia genes.
- Characterization of 44 heterozygous beta-thalassemia genes from 47 families.
Main Results:
- Fourteen distinct beta-thalassemia mutations were identified.
- Common mutations include initiation codon (CD) ATG-->AGG (23.4%), CD 17 A-->T (21.2%), and IVS-II-1 G-->A (12.7%).
- Unique mutations like Hb Korea and CD 131 CAG-->TAG were found exclusively in Koreans, suggesting distinct origins.
Conclusions:
- The Korean beta-thalassemia mutation spectrum is characteristic of low-prevalence areas but distinct from neighboring countries.
- Specific mutations (ATG-->AGG, IVS-II-1 G-->A with CD 91 C-->T) may share a common Far Eastern origin.
- Other mutations (CD17 A-->T, CD 41/42-TTCT) suggest introduction from Southern China.